Wikidata

(Q53251221)

English

Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: clinical benefit with optimal patient selection.

scientific article published on 6 May 2011

In more languages

Statements

title
Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: clinical benefit with optimal patient selection. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21529987
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/21529987
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53251221&oldid=1646970530"